Opening New Frontiers By Advancing The Promise of PI Signaling Pathways

Barbara Dalton, Ph.D.

Select a team to find out more

Barbara Dalton, Ph.D.

Barbara Dalton, Ph.D.

Vice President Venture Capital, Worldwide Business Development, Pfizer, Inc.

Dr. Barbara Dalton runs Pfizer’s Venture Investments, managing the current private equity portfolio and advising on equity transactions. 

Barbara was a founding member of EuclidSR Partners, a private venture capital firm.  She began her business career as a research scientist at the former SmithKline before moving to the drug maker’s venture capital subsidiary, S.R. One, Ltd.  Since then, she has managed diverse fund and company investments throughout the world.  Barbara advises the Dean of Eberly College of Science at Penn State University and serves on the board of the Penn State Research Foundation and leads the Healthcare Investing Group of the New York City Investment Fund.  She is a former member of the Board of Directors of the Alzheimer’s Disease Research Foundation, the NY Biotech Association and the National Venture Capital Association.  

Barbara earned a Ph.D. in immunology and microbiology from The Medical College of Pennsylvania (now the Drexel University College of Medicine) after completing her undergraduate work at Penn State University.